Drug treatment for myotonia. [PDF]
Spillane J +6 more
europepmc +1 more source
Acetazolamide-responsive myotonia with a novel Ile239Thr mutation in SCN4A gene: a case report. [PDF]
Yadav J +3 more
europepmc +1 more source
Unraveling the pharmacological and therapeutic potential of Ranolazine beyond antianginal drug use: a new insight. [PDF]
Singh D +2 more
europepmc +1 more source
Novel compound heterozygous mutations in SCN4A as a potential genetic cause contributing to myopathic manifestations: A case report and literature review. [PDF]
Han JY, Park J.
europepmc +1 more source
A retrospective study of accuracy and usefulness of electrophysiological exercise tests. [PDF]
Periviita V, Jokela M, Palmio J, Udd B.
europepmc +1 more source
A Korean family with Arg1448Cys mutation of SCN4A channel causing paramyotonia congenita: electrophysiologic, histopathologic, and molecular genetic studies. [PDF]
Kim DS +7 more
europepmc +1 more source
Carbamazepine treatment of myotonia congenita in a cat. [PDF]
Lopez Bonilla GV +3 more
europepmc +1 more source
Clinical, electrophysiological, and molecular genetic studies in a new family with paramyotonia congenita. [PDF]
Davies NP +5 more
europepmc +1 more source
Preclinical study of the antimyotonic efficacy of safinamide in the myotonic mouse model. [PDF]
Canfora I +9 more
europepmc +1 more source

